© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Isavuconazole Sulfate stands out as a finely-engineered pharmaceutical raw material. Produced as a part of the azole antifungal class, it takes on crucial significance in the treatment of invasive fungal infections, especially for immunocompromised patients or those with limited treatment options. Seen in solid form, its reliable presence in crystal or powder format makes it an essential component in active pharmaceutical ingredient synthesis and formulations. The purity and molecular integrity required for such ingredients drive interest in its physical and chemical properties, as even minor impurities or inconsistencies can change the therapeutic profile drastically.
Direct exposure reveals that Isavuconazole Sulfate appears as a white or off-white crystalline powder. This material carries a molecular formula of C22H17F2N5O2•H2SO4, reflecting the addition of sulfate. Its molecular weight sits close to 510.47 g/mol. Density clocks in at roughly 1.41 g/cm³, a factor that plays into how the substance behaves in handling and compounding. From experience working with comparable crystalline solids, it’s obvious that flow, compaction, and dissolution depend heavily on the fineness of the powder and the integrity of the crystalline structure. In typical storage, the compound remains stable if kept in a cool, dry place away from light and moisture. Poor storage conditions alter its reactivity, potentially reducing potency or creating safety risks in large-scale production settings.
Key specifications for Isavuconazole Sulfate involve purity levels that often exceed 99%, both to satisfy safety standards and guarantee clinical effectiveness. As an organic chemical, the molecule demonstrates firm resistance to degradation under standard processing temperatures but remains hygroscopic, drawing in moisture if packaging fails. Handling as flakes, powder, or even loosely packed crystals, it calls for dust control measures to reduce inhalation. For those who have managed raw azole substances, it becomes clear how persistent the dust can be and how it affects storage and device calibration, especially in precise laboratory or manufacturing environments.
The compound most frequently comes as a refined powder; less often, it forms larger flakes or crystals, but pearls and liquid solutions are rare due to stability concerns and solvent compatibility. Powder format remains popular for blending into finished pharmaceutical products, since it dissolves efficiently in grooved laboratory tests, while solutions may get formulated only under strictly controlled solvent conditions. Material in crystal habit delivers reliable measurement and mixing, but optimal reconstitution relies on careful equipment calibration to ensure dose accuracy.
As a chemical raw material moving through international channels, Isavuconazole Sulfate generally falls under HS Code 293499. This classification tags it with other heterocyclic compounds, useful in identifying duties and regulations during import and export. Laboratory experience proves that clear documentation—matching the chemical name, molecular formula, and HS code—prevents customs hang-ups and speeds distribution to medical sites in need of the product.
Direct handling of Isavuconazole Sulfate brings up several safety topics. Like many azole derivatives, exposure through inhalation or skin contact should be minimized. Material safety data sheets list it as harmful if swallowed or absorbed, indicating a need for gloves, dust masks, and goggles in its manipulation. Cleanup after spills demands strict protocols, as the light, airy powder can travel far from its original site. Sourcing pharmaceutical-grade raw materials calls for traceability and testing at every step, both on receipt and before compounding. Poorly controlled sourcing opens up the risk of impurities, which—based on real-world recalls—can put patient safety at risk and damage manufacturing reputations overnight.
Handling powders with a density near 1.41 g/cm³, workers find storage density straightforward, but shelf-life extends only with proper ambient controls. Exposure to humidity or high temperature introduces clumping and reduced solubility, which undercuts the precise delivery of the active ingredient in finished medications. Storage bins lined with desiccants and quality-assurance checks matter at every stage, pressures anyone who has worked with tricky, humidity-sensitive medications will recognize. Unstable storage conditions often lead to product recalls, wasted batches, and wasted investments—problems every stakeholder in the supply chain tries to avoid.
A few practical adjustments can make a difference in how Isavuconazole Sulfate gets managed. Consistent batch testing right down to the microscopic level tracks changes in crystalline structure and purity—crucial for companies who’ve faced regulatory audits. Transparent supplier relationships, further detailed by certificates of analysis, add another layer of security, so every shipment matches the quality required in pharmaceutical processes. Temperature- and humidity-controlled storage cut down on decomposition and failure rates. On the human side, clear safety training for all personnel, together with investment in personal protective equipment, keeps occupational hazards in check and protects the supply chain from disruption.
Traceability sits at the core of compliance, as the story of any chemical from initial synthesis to end-user application gets documented. For Isavuconazole Sulfate, being able to pinpoint the origin of raw materials, every handoff, and each round of analysis answers to both regulatory bodies and healthcare clients. FDA and EMA guidelines mandate this degree of transparency, where even a small lapse can fast-track a product recall and erode years of credibility. Drawing from experience, maintaining meticulous records, and seeing quick responses to deviations build trust in a heavily scrutinized field—and help keep vital medications available for those who need them.
